Ciocanel Oana, Power Kevin, Eriksen Ann
Sexual Health and Blood Borne Virus Managed Care Network, Public Health Directory, NHS Tayside, Kings Cross Hospital, Dundee, United Kingdom.
Adult Psychological Therapies Service, NHS Tayside, Dundee, United Kingdom.
Sex Med. 2019 Sep;7(3):251-269. doi: 10.1016/j.esxm.2019.06.001. Epub 2019 Jul 9.
Sexual dysfunction in men is common, and optimal treatment is complex. Although several systematic reviews concerning treatment approaches exist, a comprehensive overview without limitations concerning the population, interventions, or outcomes is lacking.
To conduct a "review of reviews" to compare the effectiveness of pharmacologic, non-pharmacologic, and combined interventions.
9 electronic databases, relevant journals, and reference lists up to July 2018 were searched. For each intervention, only the most recent and comprehensive meta-analysis or systematic review was included. The methodologic quality of the reviews was appraised using the Assessment of Multiple Systematic Reviews-2 tool.
Sexual functioning (via intravaginal ejaculatory latency time and international index of erectile function), sexual satisfaction, and adverse effects.
30 systematic reviews were included. For premature ejaculation, several treatments, including oral pharmacotherapy (selective serotonin inhibitors, phosphodiesterase type 5 [PDE5] inhibitors, tricyclic antidepressants, and opioid analgesics), topical anesthetics, and combined drug and behavioral therapies demonstrated significant improvements of 1-5 minutes in the intravaginal ejaculatory latency time. Pharmacologic interventions (PDE5 inhibitors, penile injection, and testosterone), shockwave therapy, lifestyle modifications, and combined therapies (PDE5 inhibitors and psychological intervention) were effective in treating erectile dysfunction. Most pharmacologic therapies were associated with adverse effects.
There is suggestive evidence that pharmacologic interventions or combined therapies are more effective than non-pharmacologic interventions for treating sexual dysfunction in men; however, a range of treatment options should be presented to individual patients so they may consider the risks and benefits of treatments differently. Evidence related to behavioral and psychological interventions is insufficient compared with that related to drug trials, highlighting the necessity for larger and better randomized controlled trials. Ciocanel O, Power K, Eriksen A. Interventions to Treat Erectile Dysfunction and Premature Ejaculation: An Overview of Systematic Reviews. Sex Med 2019;7:251-269.
男性性功能障碍很常见,最佳治疗方法很复杂。尽管存在一些关于治疗方法的系统评价,但缺乏对人群、干预措施或结果没有限制的全面概述。
进行一项“综述的综述”,以比较药物、非药物和联合干预措施的有效性。
检索了9个电子数据库、相关期刊以及截至2018年7月的参考文献列表。对于每种干预措施,仅纳入最新和最全面的荟萃分析或系统评价。使用多重系统评价评估-2工具评估综述的方法学质量。
性功能(通过阴道内射精潜伏期和国际勃起功能指数)、性满意度和不良反应。
纳入了30项系统评价。对于早泄,几种治疗方法,包括口服药物治疗(选择性5-羟色胺再摄取抑制剂、5型磷酸二酯酶[PDE5]抑制剂、三环类抗抑郁药和阿片类镇痛药)、局部麻醉剂以及药物与行为联合治疗,均显示阴道内射精潜伏期有1至5分钟的显著改善。药物干预(PDE5抑制剂、阴茎注射和睾酮)、冲击波治疗、生活方式改变以及联合治疗(PDE5抑制剂和心理干预)对治疗勃起功能障碍有效。大多数药物治疗都伴有不良反应。
有提示性证据表明,药物干预或联合治疗在治疗男性性功能障碍方面比非药物干预更有效;然而,应向个体患者提供一系列治疗选择,以便他们可以不同地考虑治疗的风险和益处。与药物试验相关的证据相比,与行为和心理干预相关的证据不足,这突出了进行更大规模和更好的随机对照试验的必要性。乔卡内尔O、鲍尔K、埃里克森A。治疗勃起功能障碍和早泄的干预措施:系统评价综述。性医学2019;7:251-269。